You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: PP31 Roles of microRNAs in myeloid malignancies driven by activated tyrosine kinases

€3.03

SKU: product-article-16310 Category: General

Description
Reviews (0)

Description

PP31 Roles of microRNAs in myeloid malignancies driven by activated tyrosine kinases

Reviews

There are no reviews yet.

Be the first to review “Article: PP31 Roles of microRNAs in myeloid malignancies driven by activated tyrosine kinases”

You must be logged in to post a review.

Top

Article: PP31 Roles of microRNAs in myeloid malignancies driven by activated tyrosine kinases

Description

Reviews

Related products

Article: Highlights in breast cancer

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in gynaecological cancers

Article: Highlights in breast cancer